JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, P.
Right arrow Articles by Michaeli, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, P.
Right arrow Articles by Michaeli, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 32, 22337-22344, August 6, 1999

The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion

Ping HanDagger , John WerberDagger , Manju Surana§, Norman Fleischer§, and Tamar MichaeliDagger

From the Departments of Dagger  Developmental and Molecular Biology and § Medicine, Albert Einstein College of Medicine, Bronx, New York 10461

To understand the role cAMP phosphodiesterases (PDEs) play in the regulation of insulin secretion, we analyzed cyclic nucleotide PDEs of a pancreatic beta -cell line and used family and isozyme-specific PDE inhibitors to identify the PDEs that counteract glucose-stimulated insulin secretion. We demonstrate the presence of soluble PDE1C, PDE4A and 4D, a cGMP-specific PDE, and of particulate PDE3, activities in beta TC3 insulinoma cells. Selective inhibition of PDE1C, but not of PDE4, augmented glucose-stimulated insulin secretion in a dose-dependent fashion thus demonstrating that PDE1C is the major PDE counteracting glucose-dependent insulin secretion from beta TC3 cells. In pancreatic islets, inhibition of both PDE1C and PDE3 augmented glucose-dependent insulin secretion. The PDE1C of beta TC3 cells is a novel isozyme possessing a Km of 0.47 µM for cAMP and 0.25 µM for cGMP. The PDE1C isozyme of beta TC3 cells is sensitive to 8-methoxymethyl isobutylmethylxanthine and zaprinast (IC50 = 7.5 and 4.5 µM, respectively) and resistant to vinpocetine (IC50 > 100 µM). Increased responsiveness of PDE1C activity to calcium/calmodulin is evident upon exposure of cells to glucose. Enhanced cAMP degradation by PDE1C, due to increases in its responsiveness to calcium/calmodulin and in intracellular calcium, constitutes a glucose-dependent feedback mechanism for the control of insulin secretion.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
A. Dov, E. Abramovitch, N. Warwar, and R. Nesher
Diminished Phosphodiesterase-8B Potentiates Biphasic Insulin Response to Glucose
Endocrinology, February 1, 2008; 149(2): 741 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. G. Holz, E. Heart, and C. A. Leech
Synchronizing Ca2+ and cAMP oscillations in pancreatic {beta}-cells: a role for glucose metabolism and GLP-1 receptors?Focus on "Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic {beta}-cell: a computational approach"
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C4 - C6.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
C. Yan, C. L. Miller, and J.-i. Abe
Regulation of Phosphodiesterase 3 and Inducible cAMP Early Repressor in the Heart
Circ. Res., March 2, 2007; 100(4): 489 - 501.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
H. A Walz, L. Harndahl, N. Wierup, E. Zmuda-Trzebiatowska, F. Svennelid, V. C Manganiello, T. Ploug, F. Sundler, E. Degerman, B. Ahren, et al.
Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.
J. Endocrinol., June 1, 2006; 189(3): 629 - 641.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev, October 1, 2005; 85(4): 1303 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. A. Goraya, N. Masada, A. Ciruela, and D. M. F. Cooper
Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1A
J. Biol. Chem., September 24, 2004; 279(39): 40494 - 40504.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Harndahl, N. Wierup, S. Enerback, H. Mulder, V. C. Manganiello, F. Sundler, E. Degerman, B. Ahren, and L. S. Holst
{beta}-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology
J. Biol. Chem., April 9, 2004; 279(15): 15214 - 15222.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. H. Maurice, D. Palmer, D. G. Tilley, H. A. Dunkerley, S. J. Netherton, D. R. Raymond, H. S. Elbatarny, and S. L. Jimmo
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
Mol. Pharmacol., September 1, 2003; 64(3): 533 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. E. Doyle and J. M. Egan
Pharmacological Agents That Directly Modulate Insulin Secretion
Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Harndahl, X.-J. Jing, R. Ivarsson, E. Degerman, B. Ahren, V. C. Manganiello, E. Renstrom, and L. S. Holst
Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic beta -Cell Exocytosis and Release of Insulin
J. Biol. Chem., September 27, 2002; 277(40): 37446 - 37455.
[Abstract] [Full Text] [PDF]

Home page
 Chem SensesHome page
J. A. Cherry and V. Pho
Characterization of cAMP Degradation by Phosphodiesterases in the Accessory Olfactory System
Chem Senses, September 1, 2002; 27(7): 643 - 652.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Turner and P. Arvan
Protein Traffic from the Secretory Pathway to the Endosomal System in Pancreatic beta -Cells
J. Biol. Chem., May 5, 2000; 275(19): 14025 - 14030.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Hetman, S. H. Soderling, N. A. Glavas, and J. A. Beavo
Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase
PNAS, January 4, 2000; 97(1): 472 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. J. Travis, C. J. Jorgez, T. Merdiushev, B. H. Jones, D. M. Dess, L. Diaz-Cueto, B. T. Storey, G. S. Kopf, and S. B. Moss
Functional Relationships between Capacitation-dependent Cell Signaling and Compartmentalized Metabolic Pathways in Murine Spermatozoa
J. Biol. Chem., March 2, 2001; 276(10): 7630 - 7636.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Ma, S. Ramanadham, M. Wohltmann, A. Bohrer, F.-F. Hsu, and J. Turk
Studies of Insulin Secretory Responses and of Arachidonic Acid Incorporation into Phospholipids of Stably Transfected Insulinoma Cells That Overexpress Group VIA Phospholipase A2 (iPLA2beta ) Indicate a Signaling Rather Than a Housekeeping Role for iPLA2beta
J. Biol. Chem., April 13, 2001; 276(16): 13198 - 13208.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.